Neuronet convenes annual event on European research collaboration in Alzheimer’s disease & beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
ADAPTED
An effective strategy for overcoming the limitations of often underpowered single-OMICS studies
Alzheimer’s disease (AD) is the most common form of dementia, currently affecting 35 million people
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
Biosamples from people with Alzheimer’s disease, Mild Cognitive Impairment or healthy individuals accessible for research purposes
The Innovative Medicines Initiative funded ADAPTED project aimed to support the development of new medicines
Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
The ADAPTED project came to a close on 30th September
The ADAPTED project came to a close on 30th September. After four years of hard
ADAPTED enters its final month
The ADAPTED (Alzheimer’s Disease Apolipoprotein Pathology for Treatment Elucidation and Development) project is a major
ADAPTED and AMYPAD to hold a Featured Research Session at AAIC2020
We are pleased to report that both ADAPTED and AMYPAD projects will hold a Featured
Spotlight on early-career researchers: a Neuronet interview with Tania Fowke and Shahzad Ahmad
Neuronet spoke to two early-career researchers (ECRs) working on the Innovative Medicines Initiative’s ADAPTED project, Tania Fowke and Shahzad Ahmad.
PHAGO project holds 4th General Assembly Meeting in Erl Wood
With the PHAGO (Inflammation and Alzheimer’s disease: modulating microglia function – focussing on TREM2 and